Clinical reality: Cerebrolysin used in some regions clinically
Yes, but temperature control is the critical constraint
Another important factor with retractions is that they appear to be more common in journals with higher impact factors (Brembs, Button & Munaf, 2013), and this should not surprise us as these journals are prone to publishing studies with confirmation bias (Forstmeier, Wagenmakers & Parker, 2017
BPC-157 for Sports Injuries: What a Systematic Review of the Evidence Actually Shows. HSS journal : the musculoskeletal journal of Hospital for Special Surgery.Study breakdown PubMed 2RPEP-12503McGuire, Flynn P et al
10.1016/s0304-3940(01)01989-9 165 LampteyR
The FDA Adverse Event Reporting System now shows a reporting odds ratio of 2.46 for alopecia with semaglutide, meaning hair loss reports are nearly two and a half times higher than expected